FDA
approval
· 2025-02-11
FDA Approved: ZOLMITRIPTAN OD — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
Summary
FDA approved a supplemental application to authorize Zolmitriptan Oral Disintegrating Tablet (OD) for acute treatment of migraine, manufactured by Jubilant Cadi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZOLMITRIPTAN OD (ZOLMITRIPTAN)